PlainRecalls
FDA Devices Moderate Class II Terminated

IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi Anti HBc

Reported: May 16, 2018 Initiated: January 2, 2018 #Z-1675-2018

Product Description

IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi Anti HBc

Reason for Recall

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

Details

Units Affected
N/A
Distribution
Nationwide and Canada, Mexico, and Thailand
Location
Tarrytown, NY

Frequently Asked Questions

What product was recalled?
IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi Anti HBc. Recalled by Siemens Healthcare Diagnostics, Inc.. Units affected: N/A.
Why was this product recalled?
Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 16, 2018. Severity: Moderate. Recall number: Z-1675-2018.